Literature DB >> 6389522

Pharmacologic basis and treatment of cigarette smoking.

J E Henningfield.   

Abstract

Data are reviewed which support the contention of the American Psychiatric Association and the U.S. Public Health Service that cigarette smokers may become addicted to nicotine. Available data indicate that 1) tobacco use shares many factors in common with previously studied forms of drug abuse--most notably, narcotic addiction, 2) the rate and pattern of cigarette smoking are partially determined by nicotine dose level, and 3) nicotine meets established criteria for a prototypic drug of abuse. These findings have implications for the understanding and treatment not only of cigarette smoking but of other forms of drug abuse and psychiatric disorders in which tobacco use is a cofactor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389522

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  11 in total

Review 1.  Nicotine dependence: a preventable risk factor for other diseases.

Authors:  C Cohen; J E Henningfield
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

2.  Euphoriant effects of nicotine in smokers.

Authors:  C S Pomerleau; O F Pomerleau
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 3.  Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire.

Authors:  K O Fagerstrom; N G Schneider
Journal:  J Behav Med       Date:  1989-04

Review 4.  Health consequences of using smokeless tobacco: summary of the Advisory Committee's report to the Surgeon General.

Authors:  J W Cullen; W Blot; J Henningfield; G Boyd; R Mecklenburg; M M Massey
Journal:  Public Health Rep       Date:  1986 Jul-Aug       Impact factor: 2.792

5.  Mouse strain-specific acute respiratory effects of nicotine unrelated to nicotine metabolism.

Authors:  A J Bloom
Journal:  Toxicol Mech Methods       Date:  2019-06-21       Impact factor: 2.987

6.  Smoking-associated changes in the serotonergic systems of discrete regions of human brain.

Authors:  M E Benwell; D J Balfour; J M Anderson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Methylphenidate increases cigarette smoking.

Authors:  Craig R Rush; Stephen T Higgins; Andrea R Vansickel; William W Stoops; Joshua A Lile; Paul E A Glaser
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

8.  Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level.

Authors:  C S Pomerleau; O F Pomerleau; M J Majchrzak
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 9.  Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association.

Authors:  J E Henningfield; N L Benowitz; J Slade; T P Houston; R M Davis; S D Deitchman
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

Review 10.  The role of nicotine in tobacco use.

Authors:  J H Robinson; W S Pritchard
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.